Literature DB >> 10229828

Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function.

J R Carlyle1, A Martin, A Mehra, L Attisano, F W Tsui, J C Zúñiga-Pflücker.   

Abstract

The mouse NK1.1 Ag originally defined as NK cell receptor (NKR)-P1C (CD161) mediates NK cell activation. Here, we show that another member of the mouse CD161 family, NKR-P1B, represents a novel NK1.1 Ag. In contrast to NKR-P1C, which functions as an activating receptor, NKR-P1B inhibits NK cell activation. Association of NKR-P1B with Src homology 2-containing protein tyrosine phosphatase-1 provides a molecular mechanism for this inhibition. The existence of these two NK1.1 Ags with opposite functions suggests a potential role for NKR-P1 molecules, such as those of the Ly-49 gene family, in regulating NK cell function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229828

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  NKR-P1 biology: from prototype to missing self.

Authors:  Aruz Mesci; Belma Ljutic; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L.

Authors:  Xiaocai Yan; Bryon D Johnson; Rimas J Orentas
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Analysis of the mouse 129-strain Nkrp1-Clr gene cluster reveals conservation of genomic organization and functional receptor-ligand interactions despite significant allelic polymorphism.

Authors:  Peter Chen; Simon Bélanger; Oscar A Aguilar; Qiang Zhang; Aaron St-Laurent; M Munir Ahmad Rahim; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunogenetics       Date:  2011-06-11       Impact factor: 2.846

4.  Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.

Authors:  Masashi Emoto; Takamitsu Shimizu; Hiromi Koike; Izumi Yoshizawa; Robert Hurwitz; Stefan H E Kaufmann; Yoshiko Emoto
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

5.  An in vitro model of innate lymphoid cell function and differentiation.

Authors:  D S J Allan; C L Kirkham; O A Aguilar; L C Qu; P Chen; J H Fine; P Serra; G Awong; J L Gommerman; J C Zúñiga-Pflücker; J R Carlyle
Journal:  Mucosal Immunol       Date:  2014-08-20       Impact factor: 7.313

Review 6.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma.

Authors:  Vanaja Konduri; Dali Li; Matthew M Halpert; Dan Liang; Zhengdong Liang; Yunyu Chen; William E Fisher; Silke Paust; Jonathan M Levitt; Qizhi Cathy Yao; William K Decker
Journal:  Oncoimmunology       Date:  2016-07-22       Impact factor: 8.110

8.  Interferon-Dependent Induction of Clr-b during Mouse Cytomegalovirus Infection Protects Bystander Cells from Natural Killer Cells via NKR-P1B-Mediated Inhibition.

Authors:  Christina L Kirkham; Oscar A Aguilar; Tao Yu; Miho Tanaka; Aruz Mesci; Kuan-Lun Chu; Jason H Fine; Karen L Mossman; Rod Bremner; David S J Allan; James R Carlyle
Journal:  J Innate Immun       Date:  2017-03-14       Impact factor: 7.349

9.  Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells.

Authors:  A Awasthi; A Samarakoon; X Dai; R Wen; D Wang; S Malarkannan
Journal:  Genes Immun       Date:  2008-06-12       Impact factor: 2.676

10.  Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

Authors:  James R Carlyle; Amanda M Jamieson; Stephan Gasser; Christopher S Clingan; Hisashi Arase; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.